Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study.
The prevalence of substandard and falsified medicines in low- and middle-income countries (LMICs) is a major global public health concern. Multiple screening technologies for post-market surveillance of medicine quality have been developed but there exists no clear guidance on which technology is op...
Main Authors: | Colleen R Higgins, Betty Kobia, Sachiko Ozawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0268661 |
Similar Items
-
Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study
by: Colleen R. Higgins, et al.
Published: (2023-01-01) -
Trade in substandard and falsified medicines
by: Hagen, N, et al.
Published: (2022) -
Technologies for detecting falsified and substandard drugs in low and middle-income countries.
by: Stephanie Kovacs, et al.
Published: (2014-01-01) -
How to achieve international action on falsified and substandard medicines.
by: Attaran, A, et al.
Published: (2012) -
Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
by: Zabala, GA, et al.
Published: (2022)